Who is sponsoring NCT04980079?

NCT04980079 is sponsored by South Valley University.

What drugs are being tested in NCT04980079?

Interventions in NCT04980079: Primary ureterscopy URS, deferred ureteroscopy URS.

What condition does NCT04980079 study?

NCT04980079 studies Ureter Obstruction.

Is NCT04980079 still recruiting?

NCT04980079 is currently status unknown. Last updated 28 July 2021.

Last reviewed 2021-07-28 · How we verify

NCT04980079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Primary Versus Deferred Ureteroscopy for Calculus Anuria in Children

Status unknown NA Last updated 28 July 2021

What this trial tests

NA trial testing Primary ureterscopy URS in Ureter Obstruction in 60 participants. Status unknown.

Timeline

1 April 2021

Primary endpoint
15 November 2021

30 December 2021

Quick facts

Lead sponsor	South Valley University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 April 2021
Primary completion	15 November 2021
Estimated completion	30 December 2021
Sites	1 location across Egypt

Drugs / interventions tested

Primary ureterscopy URS
deferred ureteroscopy URS

Conditions studied

Ureter Obstruction — all drugs for Ureter Obstruction →

Sponsor

South Valley University

Who can join

Adults 1 to 12, any sex, with Ureter Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the role of both primary and deferred URS in the management of calculus anuria concerning the feasibility, clinical outcome, and cost-effectiveness in children in a comparative study

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Primary versus deferred ureteroscopy for the management of obstructive anuria secondary to ureteric urolithiasis in children: a prospective randomized study.
AbdelRazek M, Fathi A, Mohamed M, Abdel-Kader MS. · · 2022 · cited 3× · PMID 36459265 · DOI 10.1007/s00240-022-01389-0

Verify or expand the search:

Other South Valley University trials

Trials by the same sponsor.

NCT07478718 — Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy · NA · not yet recruiting
NCT07265154 — Gait Training and Artificial Intelligence · NA · recruiting
NCT07070544 — Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure · NA · not yet recruiting
NCT07128472 — Evaluation of IL 12B Genetic Polymorphism (rs3213094) · NA · recruiting
NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04980079 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by South Valley University
Last refreshed: 28 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04980079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing